×

Brian Ahrens Joins Marrone Bio Innovations as Vice President of Sales

DAVIS, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Brian Ahrens has joined the company as its Vice President of Sales. In this role, Ahrens will be responsible for driving U.S. and international sales of MBI's portfolio of products to growers through distributors and retailers of agriculture products.

Brian Ahrens, Vice President of Sales, Marrone Bio Innovations


A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=28626

Pam Marrone, Chief Executive Officer of Marrone Bio Innovations, said, "There are significant domestic and international growth opportunities for our bio-based agricultural solutions as more growers and companies put an emphasis on environmental sustainability and improved agricultural productivity. Brian strengthens our management team and sales organization as we add depth and build out our sales team in order to capitalize on these opportunities. Brian will play a critical role in driving sales and expanding our market reach for our bio-based products, which promote plant health and control unwanted pests in agriculture and water."

A veteran of the agriculture industry with 20 years of business and industry experience, Ahrens joins MBI from ADAMA Agriculture Solutions (formerly Mahkteshium Agan - MANA) where he served as Strategic Business Leader, Innovation Leader, Northern Regional Business Manager and Senior Product Manager. Prior to his time at ADAMA, Ahrens held multiple positions with BASF Corporation, Bayer CropScience, Aventis CropScience and Rhône-Poulenc Ag Company. Ahrens has a B.S. in Agricultural Business from Iowa State University, with a concentration in marketing and sales.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

As previously disclosed in the Company's Form 8-K dated September 3, 2014, the Company's Audit Committee has commenced an internal investigation. The Audit Committee has not yet concluded its investigation and the Company does not expect it will be in a position to discuss financial results until after the investigation is completed.

The uncertainty surrounding the timing and results of the Audit Committee investigation could impact the timing of Company's discussion of its financial results. Additional relevant information concerning developments in the Audit Committee investigation may be found in the Company's filings with the Securities and Exchange Commission from time to time.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

CONTACT: Media Contact: Cory Ziskind ICR 646-277-1232 Cory.Ziskind@icrinc.com

Source:Marrone Bio Innovations